Vasanthavada Madhav 4

What Happened
Vasanthavada Madhav, Chief Commercial Officer of Abeona Therapeutics (ABEO), sold 12,606 shares on July 9, 2026 in a transaction reported as a sale. The filing reports a weighted-average price of $6.96 per share for total proceeds of approximately $87,784. Footnotes indicate the shares were withheld/sold to satisfy tax-withholding obligations upon the vesting of restricted stock awards.

Key Details

• Transaction date: July 9, 2026
• Transaction type/code: Sale (S) — open market/private sale reported; sale executed as tax withholding for vested restricted stock (F1)
• Price: weighted average $6.96; reported price range $6.86–$7.04 (F2). The filer can provide the breakdown of shares sold at each price on request.
• Shares sold: 12,606; proceeds ≈ $87,784
• Shares owned after transaction: Not disclosed in this filing
• Filing timeliness: Reported with the Form 4 dated July 9, 2026 (no late filing indicated)

Context
The sale was to satisfy tax-withholding on vested restricted stock awards, a common and routine type of insider disposition that typically reflects tax obligations rather than a directional bet on the company. Retail investors should note this distinction: routine withholding sales are different from discretionary insider selling or purchases meant to signal conviction.